Mammalian orthoreoviruses (reoviruses) are highly tractable experimental models for studies of double-stranded (ds) RNA virus replication and pathogenesis. Reoviruses infect respiratory and intestinal epithelium and disseminate systemically in newborn animals. Until now, a strategy to rescue infectious virus from cloned cDNA has not been available for any member of the Reoviridae family of dsRNA viruses. We report the generation of viable reovirus following plasmid transfection of murine L929 (L) cells using a strategy free of helper virus and independent of selection. We used the reovirus reverse genetics system to introduce mutations into viral capsid proteins sigma1 and sigma3 and to rescue a virus that expresses a green fluorescent protein (GFP) transgene, thus demonstrating the tractability of this technology. The plasmid-based reverse genetics approach described here can be exploited for studies of reovirus replication and pathogenesis and used to develop reovirus as a vaccine vector.
During viral infection, cells initiate antiviral responses to contain replication and inhibit virus spread. One protective mechanism involves activation of transcription factors interferon regulatory factor-3 (IRF-3) and NF-B, resulting in secretion of the antiviral cytokine, interferon-. Another is induction of apoptosis, killing the host cell before virus disseminates. Mammalian reovirus induces both interferon- and apoptosis, raising the possibility that both pathways are initiated by a common cellular sensor. We show here that reovirus activates IRF-3 with kinetics that parallel the activation of NF-B, a known mediator of reovirus-induced apoptosis. Activation of IRF-3 requires functional retinoic acid inducible gene-I and interferon- promoter stimulator-1, but these intracellular sensors are dispensable for activation of NF-B. Interferon- promoter stimulator-1 and IRF-3 are required for efficient apoptosis following reovirus infection, suggesting a common mechanism of antiviral cytokine induction and activation of the cell death response.A primary function of the innate immune system is to detect nascent viral infections and direct subsequent cellular responses. The innate immune system responds to infection by producing a range of soluble cytokines, such as interferon- (IFN-), 5 that create an antiviral state in surrounding tissue. In response to these immune pressures, viruses have evolved multiple strategies for subverting innate immunity, which frequently center on manipulating cell death pathways. The interface between the innate immune response, viral infection, and the cellular apoptotic machinery is therefore a critical nexus of disease pathogenesis.Cells possess a variety of sensors to detect invading pathogens. Toll-like receptors (TLRs) and other pattern recognition receptors, including the nucleotide-binding oligomerization domain proteins and RNA helicases such as retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated protein-5 (Mda-5), recognize viral pathogen-associated molecular patterns (1). TLRs are expressed on the cell surface and recognize extracellular pathogen-associated molecular patterns, whereas RIG-I and Mda-5 detect intracellular viral RNA products (2-4). RIG-I recognizes viral RNAs from the Flaviviridae, Orthomyxoviridae, Paramyxoviridae, and Rhabdoviridae families, whereas Mda-5 is involved in the response to Picornaviridae (4). The ligand for RIG-I has been identified as a 5Ј triphosphate moiety on single-or double-stranded RNA (5, 6); the molecular ligand for Mda-5 is unknown. Following ligand engagement, these intracellular sensors signal through caspase activation and recruitment domains to activate the adaptor, interferon- promoter stimulator-1 (IPS-1/MAVS/ VISA/Cardif) (7-10). IPS-1 activates inhibitor of B kinase (IKK)-␣, IKK-, IKK-⑀, and Tank-binding kinase 1 to phosphorylate transcription factors, including activating transcription factor-2/c-Jun, NF-B, and interferon regulatory factor-3 (IRF-3), which direct transcription of antiviral g...
During entry into host cells, poliovirus undergoes a receptor-mediated conformational transition to form 135S particles with irreversible exposure of VP4 capsid sequences and VP1 N termini. To understand the role of VP4 during virus entry, the fate of VP4 during infection by site-specific mutants at threonine-28 of VP4 (4028T) was compared with that of the parental Mahoney type 1 virus. Three virus mutants were studied: the entry-defective, nonviable mutant 4028T.G and the viable mutants 4028T.S and 4028T.V, in which residue threonine-28 was changed to glycine, serine, and valine, respectively. We show that mutant and wild-type (WT) VP4 proteins are localized to cellular membranes after the 135S conformational transition. Both WT and viable 4028T mutant particles interact with lipid bilayers to form ion channels, whereas the entry-defective 4028T.G particles do not. In addition, the electrical properties of the channels induced by the mutant viruses are different from each other and from those of WT Mahoney and Sabin type 3 viruses. Finally, uncoating and/or cytoplasmic delivery of the viral genome is altered in the 4028T mutants: the 4028T.G lethal mutant does not release its genome into the cytoplasm, and genome delivery is slower during infection by mutant 4028T.V 135S particles than by mutant 4028T.S or WT 135S particles. The distinctive electrical characteristics of the different 4028T mutant channels indicate that VP4 sequences might form part of the channel structure. The different entry phenotypes of these VP4 mutants suggest that the ion channels may be related to VP4's role during genome uncoating and/or delivery.Poliovirus, a member of the Picornaviridae family, encapsidates its 7,400-nucleotide positive-sensed RNA genome within an icosahedrally symmetric protein shell that is formed by 60 copies of the four capsid proteins (VP1 to VP4). VP1, VP2, and VP3 form the surface of the virion, with VP1 located at each fivefold axis and VP2 and VP3 alternately positioned around each threefold axis. VP4 in its entirety as well as the amino termini of VP1, VP2, and VP3 are buried within the interior of the capsid, lying along the inner surface of the virion shell (12).Poliovirus entry into cells is initiated by binding to the poliovirus receptor (PVR) on the cell surface. PVR binding induces a conformational transition within the virus particle that leads to formation of altered particles (termed A particles) sedimenting at 135S (versus the 160S sedimentation value of the native particle) (references 8 and 23 and references therein). This conformational transition results in relocation of VP4 and the VP1 N termini from the particle interior to the virion exterior. The appearance of VP4 and VP1 domains on the particle surface is correlated with dramatic differences in the functional behavior of the native 160S and altered 135S particles. Functionally, these PVR-induced conformational rearrangements generate 135S particles that acquire the ability to bind to liposomes, to form ion channels in lipid bilayers, and ...
Cell death is a common outcome of virus infection. In some cases, cell death curbs virus replication. In others, cell death enhances virus dissemination and contributes to tissue injury, exacerbating viral disease. Three forms of cell death are observed following virus infection-apoptosis, necroptosis, and pyroptosis. In this review, I describe the core machinery needed for each of these forms of cell death. Using representative viruses, I highlight how distinct stages of virus replication initiate signaling pathways that elicit these forms of cell death. I also discuss viral strategies to overcome the deleterious effects of cell death on virus propagation and the consequences of cell death for host physiology.
Apoptosis plays an important role in the pathogenesis of reovirus encephalitis. Reovirus outer-capsid protein μ1, which functions to penetrate host cell membranes during viral entry, is the primary regulator of apoptosis following reovirus infection. Ectopic expression of full-length and truncated forms of μ1 indicates that the μ1 ϕ domain is sufficient to elicit a cell death response. To evaluate the contribution of the μ1 ϕ domain to the induction of apoptosis following reovirus infection, ϕ mutant viruses were generated by reverse genetics and analyzed for the capacity to penetrate cell membranes and elicit apoptosis. We found that mutations in ϕ diminish reovirus membrane penetration efficiency by preventing conformational changes that lead to generation of key reovirus entry intermediates. Independent of effects on membrane penetration, amino acid substitutions in ϕ affect the apoptotic potential of reovirus, suggesting that ϕ initiates apoptosis subsequent to cytosolic delivery. In comparison to wild-type virus, apoptosis-defective ϕ mutant viruses display diminished neurovirulence following intracranial inoculation of newborn mice. These results indicate that the ϕ domain of μ1 plays an important regulatory role in reovirus-induced apoptosis and disease.
Necroptosis, a regulated form of necrotic cell death, requires the activation of the RIP3 kinase. Here, we identify that infection of host cells with reovirus can result in necroptosis. We find that necroptosis requires sensing of the genomic RNA within incoming virus particles via cytoplasmic RNA sensors to produce type I interferon (IFN). While these events that occur prior to the synthesis of viral RNA are required for the induction of necroptosis, they are not sufficient. The induction of necroptosis also requires late stages of reovirus infection. Specifically, efficient synthesis of double-stranded RNA (dsRNA) within infected cells is required for necroptosis. These data indicate that viral RNA interfaces with host components at two different stages of infection to induce necroptosis. This work provides new molecular details about events in the viral replication cycle that contribute to the induction of necroptosis following infection with an RNA virus. An appreciation of how cell death pathways are regulated following viral infection may reveal strategies to limit tissue destruction and prevent the onset of disease. Cell death following virus infection can occur by apoptosis or a regulated form of necrosis known as necroptosis. Apoptotic cells are typically disposed of without activating the immune system. In contrast, necroptotic cells alert the immune system, resulting in inflammation and tissue damage. While apoptosis following virus infection has been extensively investigated, how necroptosis is unleashed following virus infection is understood for only a small group of viruses. Here, using mammalian reovirus, we highlight the molecular mechanism by which infection with a dsRNA virus results in necroptosis.
Apoptosis plays an important role in the pathogenesis of reovirus encephalitis and myocarditis in infected animals. Differences in apoptosis efficiency displayed by reovirus strains are linked to the viral 1-encoding M2 gene segment. Studies using pharmacologic inhibitors of reovirus replication demonstrate that apoptosis induction by reovirus requires viral disassembly in cellular endosomes but not RNA synthesis. Since the 1 protein functions to pierce endosomal membranes during this temporal window, these findings point to an important role for 1 in activating signaling pathways that lead to apoptosis. To understand mechanisms used by 1 to induce apoptosis, a panel of 1 mutant viruses generated by reverse genetics was analyzed for the capacities to penetrate host cell membranes, activate proapoptotic signaling pathways, evoke cell death, and produce encephalitis in newborn mice. We found that single amino acid changes within the ␦ region of 1 reduce the efficiency of membrane penetration. These mutations also diminish the capacities of reovirus to activate proapoptotic transcription factors NF-B and IRF-3 and elicit apoptosis. Additionally, we observed that following intracranial inoculation, an apoptosis-deficient 1 mutant is less virulent in newborn mice in comparison to the wild-type virus. These results indicate a critical function for the membrane penetration activity of 1 in evoking prodeath signaling pathways that regulate reovirus pathogenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.